Abdelgani S, Khattab A, Adams J, Baskoy G, et al. The impact of increased hepatic glucose production caused by empagliflozin on plasma glucose concentration in individuals with type 2 diabetes and nondiabetic individuals. Diabetes Obes Metab 2023 Dec 22. doi: 10.1111/dom.15404.
PMID: 38131252